JPH11269138A - Organic base producing agent - Google Patents

Organic base producing agent

Info

Publication number
JPH11269138A
JPH11269138A JP10071915A JP7191598A JPH11269138A JP H11269138 A JPH11269138 A JP H11269138A JP 10071915 A JP10071915 A JP 10071915A JP 7191598 A JP7191598 A JP 7191598A JP H11269138 A JPH11269138 A JP H11269138A
Authority
JP
Japan
Prior art keywords
group
formula
chloroform
solution
base
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP10071915A
Other languages
Japanese (ja)
Inventor
Yoshiharu Hizadate
祥治 膝舘
Kiyoko Kubota
聖子 久保田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Paper Mills Ltd
Original Assignee
Mitsubishi Paper Mills Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Paper Mills Ltd filed Critical Mitsubishi Paper Mills Ltd
Priority to JP10071915A priority Critical patent/JPH11269138A/en
Publication of JPH11269138A publication Critical patent/JPH11269138A/en
Ceased legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To obtain a new compound useful as an organic base precursor having the rapidity of producing a base at the time of heating compatible with the stability during the preservation. SOLUTION: This compound is represented by formula I [R<1> to R<4> are each H, an alkyl, an alkenyl, an aralkyl or an aryl; Z is a substituent group having a value of σ of >=0 when defined by the Hammett's equation; [(i)+(j)] is 3 and (i) is 1 or 2] or formula II (R<5> to R<10> are each same as R<1> to R<4> ), e.g. a compound represented by formula III. The compound represented by formula I is obtained by charging stearylamine, triethylamine and chloroform into a flask equipped with a stirrer, dropping 1.5 g of 1-chloro-2-methyl-2-propyl chloroformate thereinto under cooling with ice, continuing the stirring for 2 hr, then diluting the reactional solution with chloroform, washing the diluted reactional solution with water, dehydrating the washed solution, subsequently distilling off the chloroform under a reduced pressure and recrystallizing the prepared colorless powder from a mixed solvent of an ether with n-hexane.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、熱エネルギーによ
って塩基を発生させる有機塩基発生剤に関する。
[0001] The present invention relates to an organic base generator which generates a base by thermal energy.

【0002】[0002]

【従来の技術】有機塩基は種々の反応、例えば加水分解
反応、重合反応、呈色反応、酸化還元反応、中和反応等
に用いられる非常に汎用性の高い試薬であり、一般の商
品を構成する場合にも塩基が組み込まれている場合が数
多く存在する。
2. Description of the Related Art Organic bases are highly versatile reagents used in various reactions, for example, hydrolysis reactions, polymerization reactions, color reactions, oxidation-reduction reactions, neutralization reactions and the like, and constitute general products. In many cases, a base is incorporated.

【0003】加熱により塩基を発生する化合物を塩基プ
レカーサーと呼ぶが、この塩基プレカーサーは加熱によ
り発生した塩基が反応するように設計された種々の系に
用いられる。このような系としては例えば感熱記録材
料、熱現像感光材料、アニオン重合性の接着剤、塗装の
塗膜形成などが挙げられる。
A compound that generates a base by heating is called a base precursor, and this base precursor is used in various systems designed to react with a base generated by heating. Examples of such a system include a thermosensitive recording material, a photothermographic material, an anionic polymerizable adhesive, and formation of a coating film.

【0004】塩基プレカーサーの最も好ましい用途の一
つは熱を利用する種々の画像形成材料、例えば感熱記録
材料、熱現像感光材料等である。これらの材料では加熱
により発生した塩基が内蔵された他の化学種と反応する
ことで画像消去反応あるいは画像形成反応が進行するた
め、記録材料の性能が塩基プレカーサーの性能に大きく
依存する。塩基プレカーサーはできるだけ低い加熱温度
で迅速に塩基を生成する一方、保存中には安定でなけれ
ばならない。
One of the most preferable uses of the base precursor is various image forming materials utilizing heat, for example, heat-sensitive recording materials, photothermographic materials and the like. In these materials, the base generated by heating reacts with other built-in chemical species to cause an image erasing reaction or an image forming reaction, so that the performance of the recording material greatly depends on the performance of the base precursor. The base precursor must produce the base rapidly at the lowest possible heating temperature while being stable during storage.

【0005】代表的な塩基プレカーサーとして、米国特
許第3493374号明細書、英国特許第998949
号明細書、米国特許第4060420号明細書、特開昭
59−168441号、特開昭59−180537号、
特開昭60−237443号、特開昭61−51139
号、特開平1−68746号、特開平8−169870
号の各公報に記載されているカルボン酸と有機塩基の塩
が挙げられる。これらはいずれもカルボン酸が加熱によ
り脱炭酸することで有機塩基が遊離する性質を利用して
いる。
As typical base precursors, US Pat. No. 3,493,374 and British Patent No. 998949 are known.
No., U.S. Pat. No. 4,060,420, JP-A-59-168441, JP-A-59-180537,
JP-A-60-237443, JP-A-61-51139
JP-A-1-68746, JP-A-8-169870
And the salts of carboxylic acids and organic bases described in each of the above publications. All of these utilize the property that an organic base is released by decarboxylation of a carboxylic acid by heating.

【0006】一方、特開昭59−166943号公報に
はロッセン転位により有機塩基が放出される反応を利用
した系が記載されている。
On the other hand, JP-A-59-166943 discloses a system utilizing a reaction in which an organic base is released by Rossen rearrangement.

【0007】しかし、いずれの場合においても加熱時に
おける塩基生成の迅速性と保存中の安定性の両立という
点で十分満足できるものではなかった。
However, in any case, it has not been sufficiently satisfactory in terms of achieving both rapidity of base formation upon heating and stability during storage.

【0008】[0008]

【発明が解決しようとする課題】本発明の目的は、加熱
時における塩基生成の迅速性と保存中の安定性が両立し
た有機塩基プレカーサーを提供することである。
SUMMARY OF THE INVENTION It is an object of the present invention to provide an organic base precursor having both rapidity of base generation upon heating and stability during storage.

【0009】[0009]

【課題を解決するための手段】本発明が解決しようとす
る課題は、一般式(1)あるいは一般式(2)で表され
る化合物により達成された。
The object of the present invention has been attained by a compound represented by the general formula (1) or (2).

【0010】[0010]

【化3】 Embedded image

【0011】[0011]

【化4】 Embedded image

【0012】式(1)および式(2)中、R1〜R10
同じでも異なっても良く、それぞれ水素原子、アルキル
基、アルケニル基、アラルキル基、またはアリール基を
表し、Zはハメットの式で規定されたときに0以上のσ
値を有する置換基であり、i+j=3かつiは1あるい
は2を表す。
In the formulas (1) and (2), R 1 to R 10 may be the same or different and each represents a hydrogen atom, an alkyl group, an alkenyl group, an aralkyl group, or an aryl group, and Z represents a Hammett's group. Σ greater than or equal to 0 when specified by the formula
Is a substituent having a value, i + j = 3 and i represents 1 or 2.

【0013】一般式(1)または(2)で表される化合
物において、Zはハメットの式で規定されたときに0以
上のσ値を有する置換基である。好ましい置換基として
は、例えば、アルキルカルボニル基、アルケニルカルボ
ニル基、アラルキルカルボニル基、アリールカルボニル
基、アルキルオキシカルボニル基、アルケニルオキシカ
ルボニル基、アリールオキシカルボニル基、アラルキル
オキシカルボニル基、アルキルスルホニル基、アルケニ
ルスルホニル基、アラルキルスルホニル基、アリールス
ルホニル基、アルキルスルホキシド基、アルケニルスル
ホキシド基、アラルキルスルホキシド基、アリールスル
ホキシド基、ハロゲン、ニトロ基、またはシアノ基など
を挙げることができる。
In the compound represented by the general formula (1) or (2), Z is a substituent having a σ value of 0 or more as defined by Hammett's formula. Preferred substituents include, for example, alkylcarbonyl, alkenylcarbonyl, aralkylcarbonyl, arylcarbonyl, alkyloxycarbonyl, alkenyloxycarbonyl, aryloxycarbonyl, aralkyloxycarbonyl, alkylsulfonyl, alkenylsulfonyl Groups, aralkylsulfonyl groups, arylsulfonyl groups, alkylsulfoxide groups, alkenylsulfoxide groups, aralkylsulfoxide groups, arylsulfoxide groups, halogen, nitro groups, and cyano groups.

【0014】特に、アルキルカルボニル基、アルケニル
カルボニル基、アラルキルカルボニル基、アリールカル
ボニル基、アルキルスルホニル基、アルケニルスルホニ
ル基、アラルキルスルホニル基、アリールスルホニル
基、アルキルスルホキシド基、アルケニルスルホキシド
基、アラルキルスルホキシド基、アリールスルホキシド
基、ハロゲン、ニトロ基、またはシアノ基などの置換基
はより好ましい。
In particular, alkylcarbonyl, alkenylcarbonyl, aralkylcarbonyl, arylcarbonyl, alkylsulfonyl, alkenylsulfonyl, aralkylsulfonyl, arylsulfonyl, alkylsulfoxide, alkenylsulfoxide, aralkylsulfoxide, aryl Substituents such as sulfoxide, halogen, nitro or cyano are more preferred.

【0015】一般式(1)または(2)で表される化合
物において、R1〜R10は好ましくは水素原子、炭素数
1〜20のアルキル基、炭素数5〜14のシクロアルキ
ル基、炭素数1〜20のアルケニル基、炭素数7〜20
のアラルキル基、またはフェニル基、ナフチル基、複素
芳香環である。
In the compound represented by the general formula (1) or (2), R 1 to R 10 are preferably a hydrogen atom, an alkyl group having 1 to 20 carbon atoms, a cycloalkyl group having 5 to 14 carbon atoms, An alkenyl group having 1 to 20 carbon atoms, 7 to 20 carbon atoms
Or a phenyl group, a naphthyl group, or a heteroaromatic ring.

【0016】R1〜R10で表されるアルキル基、アルケ
ニル基、アラルキル基、およびアリール基は置換基を有
していても良く、例えば、アルキル基、アルケニル基、
アリール基、アルコキシ基、アルコキシアルキルオキシ
基、アルケニルオキシ基、アラルキルオキシ基、アラル
キルオキシアルコキシ基、アリールオキシ基、アリール
オキシアルコキシ基、アルキルカルボニル基、アルケニ
ルカルボニル基、アラルキルカルボニル基、アリールカ
ルボニル基、アルキルオキシカルボニル基、アルケニル
オキシカルボニル基、アリールオキシカルボニル基、ア
ラルキルオキシカルボニル基、アルキルカルボニルオキ
シ基、アルケニルカルボニルオキシ基、アラルキルカル
ボニルオキシ基、アリールカルボニルオキシ基、アルキ
ルスルホニル基、アルケニルスルホニル基、アラルキル
スルホニル基、アリールスルホニル基、アルキルスルホ
キシド基、アルケニルスルホキシド基、アラルキルスル
ホキシド基、アリールスルホキシド基、水酸基、ハロゲ
ン、ニトロ基、またはシアノ基などの置換基で単置換あ
るいは多置換されていてもよい。
The alkyl group, alkenyl group, aralkyl group and aryl group represented by R 1 to R 10 may have a substituent, for example, an alkyl group, an alkenyl group,
Aryl group, alkoxy group, alkoxyalkyloxy group, alkenyloxy group, aralkyloxy group, aralkyloxyalkoxy group, aryloxy group, aryloxyalkoxy group, alkylcarbonyl group, alkenylcarbonyl group, aralkylcarbonyl group, arylcarbonyl group, alkyl Oxycarbonyl group, alkenyloxycarbonyl group, aryloxycarbonyl group, aralkyloxycarbonyl group, alkylcarbonyloxy group, alkenylcarbonyloxy group, aralkylcarbonyloxy group, arylcarbonyloxy group, alkylsulfonyl group, alkenylsulfonyl group, aralkylsulfonyl group , Arylsulfonyl, alkylsulfoxide, alkenylsulfoxide, aralkylsulfoxide, ant Rusuruhokishido group, a hydroxyl group, a halogen, a nitro group, or a substituent such as a cyano group may be mono- or polysubstituted.

【0017】[0017]

【発明の実施の形態】一般式(1)で表されるの化合物
の具体例としては以下に示す(1−1)〜(2−8)が
挙げられるが本発明はこれに限定されるものではない。
DESCRIPTION OF THE PREFERRED EMBODIMENTS Specific examples of the compound represented by the general formula (1) include the following (1-1) to (2-8), but the present invention is not limited thereto. is not.

【0018】[0018]

【化5】 Embedded image

【0019】[0019]

【化6】 Embedded image

【0020】[0020]

【化7】 Embedded image

【0021】[0021]

【化8】 Embedded image

【0022】本発明の塩基プレカーサーの好ましい使用
量は、例えば、電子供与性無色染料と電子受容性化合物
を含有する感熱発色層を設けた感熱記録材料において本
発明の塩基プレカーサーを消色剤として用いる場合、該
感熱発色層に含有される電子供与性無色染料の重量の5
0%〜1000%である。また、塩基プレカーサーは1
種類または2種類以上を混合して使用しても良い。
The preferred amount of the base precursor of the present invention is, for example, the use of the base precursor of the present invention as a decoloring agent in a thermosensitive recording material provided with a thermosensitive coloring layer containing an electron-donating colorless dye and an electron-accepting compound. In this case, the weight of the electron-donating colorless dye contained in the thermosensitive coloring layer is 5%.
0% to 1000%. The base precursor is 1
You may mix and use two or more types.

【0023】[0023]

【実施例】以下本発明の化合物の具体的製造方法につい
てその一部を例示するが、本発明はこれに限定されるも
のではない。
The present invention is not limited to a specific example of a method for producing the compound of the present invention, but the present invention is not limited thereto.

【0024】実施例1 例示化合物(1−2)の合成。 撹拌機を付けたフラスコ内に、ステアリルアミン2.2
g、トリエチルアミン0.9g、クロロホルム30ml
を仕込み、氷冷下にクロロギ酸1−クロロ−2−メチル
−2−プロピル1.5gを滴下した。そのまま2時間攪
拌を続けた後、反応液をクロロホルムにて希釈し、水
洗、脱水後クロロホルムを減圧下に留去し、得られた無
色の粉体をエーテルとn−ヘキサンの混合溶媒から再結
晶し無色の結晶1.5gを得た。融点68℃。
Example 1 Synthesis of exemplified compound (1-2). In a flask equipped with a stirrer, stearylamine 2.2
g, triethylamine 0.9 g, chloroform 30 ml
And 1.5 g of 1-chloro-2-methyl-2-propyl chloroformate was added dropwise under ice cooling. After continuing stirring for 2 hours, the reaction solution was diluted with chloroform, washed with water and dehydrated, and chloroform was distilled off under reduced pressure. The obtained colorless powder was recrystallized from a mixed solvent of ether and n-hexane. 1.5 g of colorless crystals were obtained. Melting point 68 [deg.] C.

【0025】実施例2 例示化合物(1−7)の合成。 撹拌機を付けたフラスコ内に、ステアリルアミン3.5
g、トリエチルアミン1.3g、クロロホルム50ml
を仕込み、氷冷下に9−フルオレニルメチルサクシミジ
ルカーボネート4.4gをクロロホルム20mlに溶解
したものを滴下した。氷浴をはずして18時間攪拌を続
けた後、反応液をクロロホルムにて希釈し、水洗、脱水
後クロロホルムを減圧下に留去した。得られた無色の粉
体をクロロホルムとn−ヘキサンの混合溶媒から再結晶
し無色の針状晶4.0gを得た。融点98℃。
Example 2 Synthesis of exemplified compound (1-7). In a flask equipped with a stirrer, stearylamine 3.5 was added.
g, triethylamine 1.3 g, chloroform 50 ml
Was added, and a solution of 4.4 g of 9-fluorenylmethylsuccimidyl carbonate dissolved in 20 ml of chloroform was added dropwise under ice cooling. After removing the ice bath and continuing stirring for 18 hours, the reaction solution was diluted with chloroform, washed with water and dehydrated, and then chloroform was distilled off under reduced pressure. The obtained colorless powder was recrystallized from a mixed solvent of chloroform and n-hexane to obtain 4.0 g of colorless needles. Melting point 98 [deg.] C.

【0026】実施例3 例示化合物(1−8)の合成。 撹拌機を付けたフラスコ内に、2−ヒドロキシインダン
1.6g、ステアリルイソシアネート1.2g、トリエ
チルアミン1.0g、エーテル20mlを仕込み、室温
で18時間攪拌を続けた後、生じた結晶を減圧下に濾取
し、無色の針状晶2.0gを得た。融点85.5℃。
Example 3 Synthesis of exemplified compound (1-8). 1.6 g of 2-hydroxyindane, 1.2 g of stearyl isocyanate, 1.0 g of triethylamine and 20 ml of ether were charged into a flask equipped with a stirrer, and the mixture was stirred at room temperature for 18 hours. The crystals were collected by filtration to obtain 2.0 g of colorless needles. Melting point 85.5 ° C.

【0027】実施例4 例示化合物(1−11)の合成。 撹拌機を付けたフラスコ内に、エチレンシアノヒドリン
0.7g、ステアリルイソシアネート3.0g、トリエ
チルアミン1.1g、アセトン20mlを仕込み、室温
で18時間攪拌を続けた後、生じた結晶を減圧下に濾取
し、無色の針状晶2.3gを得た。融点108℃。
Example 4 Synthesis of exemplified compound (1-11) 0.7 g of ethylene cyanohydrin, 3.0 g of stearyl isocyanate, 1.1 g of triethylamine and 20 ml of acetone were charged into a flask equipped with a stirrer, and the mixture was stirred at room temperature for 18 hours. This gave 2.3 g of colorless needles. Melting point 108 [deg.] C.

【0028】実施例5 例示化合物(1−12)の合成。 撹拌機を付けたフラスコ内に、4−ヒドロキシ−2−ブ
タノン0.9g、ステアリルイソシアネート3.0g、
トリエチルアミン1.1g、アセトン20mlを仕込
み、室温で18時間攪拌を続けた後、生じた結晶を減圧
下に濾取し、無色の針状晶2.5gを得た。融点104
℃。
Example 5 Synthesis of exemplified compound (1-12). In a flask equipped with a stirrer, 0.9 g of 4-hydroxy-2-butanone, 3.0 g of stearyl isocyanate,
After stirring triethylamine (1.1 g) and acetone (20 ml) at room temperature for 18 hours, the resulting crystals were collected by filtration under reduced pressure to obtain 2.5 g of colorless needles. Melting point 104
° C.

【0029】実施例6 例示化合物(2−3)の合成。 撹拌機を付けたフラスコ内に、1,3−ジシクロヘキシ
ル−2−(2,4−ジメチルフェニル)グアニジン3.
3g、トリエチルアミン2.2g、テトラヒドロフラン
50mlを仕込み、氷冷下にクロロギ酸9−フルオレニ
ルメチル2.6gをテトラヒドロフラン20mlに溶解
したものを滴下した。氷浴をはずして18時間攪拌を続
けた後、水200mlへ投入し、酢酸エチルにて抽出し
た。酢酸エチル層を10%クエン酸水溶液にて洗い、脱
水後、酢酸エチルを減圧留去した。得られた無色のアモ
ルファス状物質をシリカゲルカラムクロマトにて精製
し、無色のアモルファス状物質として例示化合物2−3
を3.4g得た。
Example 6 Synthesis of exemplified compound (2-3). 2. In a flask equipped with a stirrer, 1,3-dicyclohexyl-2- (2,4-dimethylphenyl) guanidine.
3 g, 2.2 g of triethylamine and 50 ml of tetrahydrofuran were charged, and a solution prepared by dissolving 2.6 g of 9-fluorenylmethyl chloroformate in 20 ml of tetrahydrofuran was added dropwise under ice cooling. After removing the ice bath and continuing stirring for 18 hours, the mixture was poured into 200 ml of water and extracted with ethyl acetate. The ethyl acetate layer was washed with a 10% aqueous citric acid solution, and after dehydration, ethyl acetate was distilled off under reduced pressure. The obtained colorless amorphous substance was purified by silica gel column chromatography, and as a colorless amorphous substance, Exemplified Compound 2-3 was obtained.
3.4 g was obtained.

【0030】比較例1 N−オクタデシルメチルカルバメートの合成。 撹拌機を付けたフラスコ内に、メタノール0.3g、ス
テアリルイソシアネート3.0g、トリエチルアミン
1.1g、アセトン20mlを仕込み、室温で18時間
攪拌を続けた後、生じた結晶を減圧下に濾取し、無色の
針状晶2.5gを得た。融点71.5℃。
Comparative Example 1 Synthesis of N-octadecylmethyl carbamate. In a flask equipped with a stirrer, 0.3 g of methanol, 3.0 g of stearyl isocyanate, 1.1 g of triethylamine and 20 ml of acetone were charged, and stirring was continued at room temperature for 18 hours. The resulting crystals were collected by filtration under reduced pressure. 2.5 g of colorless needles were obtained. 71.5 ° C.

【0031】試験1 塩基プレカーサー10mmolをフラスコ内に秤量し、
150℃油浴上で30秒間加熱した。生成物を単離し発
生した塩基を秤量し、収率を求めた。結果を表1に示し
た。
Test 1 10 mmol of the base precursor was weighed into a flask,
Heated on 150 ° C. oil bath for 30 seconds. The product was isolated and the generated base was weighed to determine the yield. The results are shown in Table 1.

【0032】試験2 塩基プレカーサー10mmolをフラスコ内に秤量し、
60℃で18時間放置した後、発生した塩基を単離し分
解率を求めた。結果を表1に示した。
Test 2 10 mmol of the base precursor was weighed into a flask,
After standing at 60 ° C. for 18 hours, the generated base was isolated and the decomposition rate was determined. The results are shown in Table 1.

【0033】試験3 塩基プレカーサー約6mgを精確に秤量し、パーキンエ
ルマー社製7シリーズ熱分析システムを用い、窒素雰囲
気下で10℃/分の昇温速度で熱重量分析を室温から2
50℃の範囲で行った。塩基発生開始温度と終了温度を
表1に示した。
Test 3 Approximately 6 mg of the base precursor was accurately weighed, and thermogravimetric analysis was performed from room temperature to room temperature under a nitrogen atmosphere at a heating rate of 10 ° C./min using a 7 series thermal analysis system manufactured by Perkin Elmer.
The test was performed in the range of 50 ° C. Table 1 shows the base generation start temperature and base generation temperature.

【0034】[0034]

【表1】 [Table 1]

【0035】[0035]

【発明の効果】表1から明らかなように、加熱時におけ
る塩基生成の迅速性と保存中の安定性が両立した塩基プ
レカーサーを提供することが可能になった。
As is evident from Table 1, it has become possible to provide a base precursor having both quickness of base formation during heating and stability during storage.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 FI C07C 279/18 C07C 279/24 279/24 317/18 317/18 C09K 3/00 K C09K 3/00 B41M 5/18 109 ──────────────────────────────────────────────────の Continued on the front page (51) Int.Cl. 6 Identification code FI C07C 279/18 C07C 279/24 279/24 317/18 317/18 C09K 3/00 K C09K 3/00 B41M 5/18 109

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 下記一般式(1)で表される有機塩基発
生剤。 【化1】 (式(1)中、R1、R2、R3およびR4は同じでも異な
っても良く、それぞれ水素原子、アルキル基、アルケニ
ル基、アラルキル基、またはアリール基を表し、Zはハ
メットの式で規定されたときに0以上のσ値を有する置
換基であり、i+j=3かつiは1あるいは2を表
す。)
1. An organic base generator represented by the following general formula (1). Embedded image (In the formula (1), R 1 , R 2 , R 3 and R 4 may be the same or different and each represents a hydrogen atom, an alkyl group, an alkenyl group, an aralkyl group or an aryl group, and Z is a Hammet's formula. Is a substituent having a sigma value of 0 or more when specified by, i + j = 3 and i represents 1 or 2.)
【請求項2】 下記一般式(2)で表される有機塩基発
生剤。 【化2】 (式(2)中、R5、R6、R7、R8、R9およびR10
同じでも異なっても良く、それぞれ水素原子、アルキル
基、アルケニル基、アラルキル基、またはアリール基を
表し、Zはハメットの式で規定されたときに0以上のσ
値を有する置換基であり、i+j=3かつiは1あるい
は2を表す。)
2. An organic base generator represented by the following general formula (2). Embedded image (In the formula (2), R 5 , R 6 , R 7 , R 8 , R 9 and R 10 may be the same or different and each represents a hydrogen atom, an alkyl group, an alkenyl group, an aralkyl group, or an aryl group. , Z is 0 or more σ as defined by Hammett's equation
Is a substituent having a value, i + j = 3 and i represents 1 or 2. )
JP10071915A 1998-03-20 1998-03-20 Organic base producing agent Ceased JPH11269138A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10071915A JPH11269138A (en) 1998-03-20 1998-03-20 Organic base producing agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10071915A JPH11269138A (en) 1998-03-20 1998-03-20 Organic base producing agent

Publications (1)

Publication Number Publication Date
JPH11269138A true JPH11269138A (en) 1999-10-05

Family

ID=13474322

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10071915A Ceased JPH11269138A (en) 1998-03-20 1998-03-20 Organic base producing agent

Country Status (1)

Country Link
JP (1) JPH11269138A (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007111092A1 (en) 2006-03-24 2007-10-04 Konica Minolta Medical & Graphic, Inc. Transparent barrier sheet and method for producing transparent barrier sheet
WO2010064632A1 (en) * 2008-12-02 2010-06-10 和光純薬工業株式会社 Photo-base generator
JP2011508246A (en) * 2007-12-13 2011-03-10 インターナショナル・ビジネス・マシーンズ・コーポレーション Multi-exposure method using photoresist composition and multilayer resist system
EP2368875A1 (en) * 2008-12-02 2011-09-28 Wako Pure Chemical Industries, Ltd. Photobase generator
US8895776B2 (en) 2008-03-18 2014-11-25 Arena Pharmaceuticals, Inc. Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
US8940891B2 (en) 2008-12-08 2015-01-27 Arena Pharmaceuticals, Inc. Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
US9012478B2 (en) 2008-11-26 2015-04-21 Arena Pharmaceuticals, Inc. Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
CN106154747A (en) * 2015-05-15 2016-11-23 罗门哈斯电子材料韩国有限公司 Light alkali producing agent and comprise its photo-corrosion-resisting agent composition
US10537546B2 (en) 2014-10-23 2020-01-21 Arena Pharmaceuticals, Inc. Method of treating conditions related to the PGI2 receptor
US11123298B2 (en) 2017-03-01 2021-09-21 Arena Pharmaceuticals, Inc. Compositions comprising PGI2-receptor agonists and processes for the preparation thereof

Cited By (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007111092A1 (en) 2006-03-24 2007-10-04 Konica Minolta Medical & Graphic, Inc. Transparent barrier sheet and method for producing transparent barrier sheet
JP2011508246A (en) * 2007-12-13 2011-03-10 インターナショナル・ビジネス・マシーンズ・コーポレーション Multi-exposure method using photoresist composition and multilayer resist system
US8895776B2 (en) 2008-03-18 2014-11-25 Arena Pharmaceuticals, Inc. Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
US10668033B2 (en) 2008-03-18 2020-06-02 Arena Pharmaceuticals, Inc. Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
US9663500B2 (en) 2008-11-26 2017-05-30 Arena Pharmaceuticals, Inc. Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
US10214518B2 (en) 2008-11-26 2019-02-26 Arena Pharmaceuticals, Inc. Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
US10689372B2 (en) 2008-11-26 2020-06-23 Arena Pharmaceuticals, Inc. Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
US9012478B2 (en) 2008-11-26 2015-04-21 Arena Pharmaceuticals, Inc. Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
US11098034B2 (en) 2008-11-26 2021-08-24 Arena Pharmaceuticals, Inc. Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
KR20110106859A (en) * 2008-12-02 2011-09-29 와코 쥰야꾸 고교 가부시키가이샤 Photobase generator
US8957212B2 (en) 2008-12-02 2015-02-17 Wako Pure Chemical Industries, Ltd. Photobase generator
EP2368875A4 (en) * 2008-12-02 2012-08-08 Wako Pure Chem Ind Ltd Photobase generator
WO2010064632A1 (en) * 2008-12-02 2010-06-10 和光純薬工業株式会社 Photo-base generator
EP2368875A1 (en) * 2008-12-02 2011-09-28 Wako Pure Chemical Industries, Ltd. Photobase generator
US10138210B2 (en) 2008-12-08 2018-11-27 Arena Pharmaceuticals, Inc. Substituted pyridazines as prostacyclin receptor modulators
US8940891B2 (en) 2008-12-08 2015-01-27 Arena Pharmaceuticals, Inc. Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
US10793529B2 (en) 2008-12-08 2020-10-06 Arena Pharmaceuticals, Inc. Substituted pyridazines and 1,2,4-triazines as prostacyclin receptor modulators
US10537546B2 (en) 2014-10-23 2020-01-21 Arena Pharmaceuticals, Inc. Method of treating conditions related to the PGI2 receptor
US11826337B2 (en) 2014-10-23 2023-11-28 Arena Pharmaceuticals, Inc. Method of treating conditions related to the PGI2 receptor
US10688076B2 (en) 2014-10-23 2020-06-23 Arena Pharmaceuticals, Inc. Method of treating conditions related to the PGI2 receptor
US11426377B2 (en) 2014-10-23 2022-08-30 Arena Pharmaceuticals, Inc. Method of treating conditions related to the PGI2 receptor
US11000500B2 (en) 2014-10-23 2021-05-11 Arena Pharmaceuticals, Inc. Method of treating conditions related to the PGI2 receptor
CN106154747A (en) * 2015-05-15 2016-11-23 罗门哈斯电子材料韩国有限公司 Light alkali producing agent and comprise its photo-corrosion-resisting agent composition
CN106154747B (en) * 2015-05-15 2020-10-16 罗门哈斯电子材料韩国有限公司 Photobase generators and photoresist compositions comprising the same
JP2016218438A (en) * 2015-05-15 2016-12-22 ローム・アンド・ハース・エレクトロニック・マテリアルズ・コリア・リミテッド Photobase generators and photoresist compositions comprising the same
US11123298B2 (en) 2017-03-01 2021-09-21 Arena Pharmaceuticals, Inc. Compositions comprising PGI2-receptor agonists and processes for the preparation thereof
US11826471B2 (en) 2017-03-01 2023-11-28 Arena Pharmaceuticals, Inc. Compositions comprising PGI2-receptor agonists and processes for the preparation thereof

Similar Documents

Publication Publication Date Title
JPH11269138A (en) Organic base producing agent
JPS5922711B2 (en) Method for producing benzoxazolinone derivatives
JP2806714B2 (en) Fluoran compound and method for producing the same
JP4138067B2 (en) Method for producing methine derivative
HU190367B (en) Process for producing 1-carbamoyl-1,3-bracket-3,5-dichloro-phenyl-bracket closed-hidanthoines and the intermediate 1-chloro-carbonyl-3-bracket-3,5-dichloro-phenyl-bracket closed-hidanthoine
US3743668A (en) Cyanoethylation of aminophenols
IL31463A (en) 1-formyl-3-nitro-azacycloalkan-2-ones and process for their production
SU1313856A1 (en) Method for producing derivatives of cis- or trans-diaminodibenzoyl-dibenzo-18-crown-6
CN110894186B (en) Preparation method of pimavanserin and intermediate thereof
JPH0529375B2 (en)
US3524863A (en) 9 - oxo - 2 - cyano - 2,3(1h) - xanthenedicarboximide compounds and process of preparation
JPS5840939B2 (en) Method for producing cyclohexanedione derivatives
JPH04323267A (en) Production of trimethine dye
US3152130A (en) Process for preparing actiphenols
JPH10310567A (en) Crystallization of 3-amino-2-(n-alkoxycarbonyl) aminopropionic acid ester-substituted benzenesulfonic acid salt
JPS58964A (en) Synthesis of 6-aminonicotic acid nicotinyl ester
JP2002332269A (en) Novel dialkoxyamide oxime derivative and method of producing the same
SU482453A1 (en) Method for preparing 2-phenacylquinoxalon-3
JPS5829314B2 (en) Method for producing O-alkyl-O-phenyl ester of thionophosphonic acid or thionolinic acid
US3152178A (en) Nu-alkyl-alpha-alpha-diaryl-beta-alkylamino-propionamides
JPH069466A (en) 3,4-disubstituted-1-naphthol derivative and its production
GB1565250A (en) Dihydropimaramide derivatives
JP2000044551A (en) Production of 3-substituted-3-oxo-2-(2,4-oxazolidinedion-3-yl) propionamide compound
JPH04108864A (en) Trimethin compound
JPS62255461A (en) N-alkyl-substituted-beta-aminocrotonamide

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060131

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060403

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20060606

A045 Written measure of dismissal of application

Free format text: JAPANESE INTERMEDIATE CODE: A045

Effective date: 20061024